4//SEC Filing
Ragatz William 4
Accession 0000899243-20-002306
CIK 0001734517other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 6:33 PM ET
Size
7.0 KB
Accession
0000899243-20-002306
Insider Transaction Report
Form 4
Ragatz William
VP, Head of Commercial
Transactions
- Exercise/Conversion
Common Stock
2020-01-27$5.22/sh+16,250$84,825→ 16,250 total - Exercise/Conversion
Stock Option (right to buy)
2020-01-27−16,250→ 48,750 totalExercise: $5.22Exp: 2029-02-24→ Common Stock (16,250 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the shares on January 7, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 7, 2020 and ending on January 7, 2023.
Documents
Issuer
Viela Bio, Inc.
CIK 0001734517
Entity typeother
Related Parties
1- filerCIK 0001789298
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 6:33 PM ET
- Size
- 7.0 KB